Glasgow Prognostic Score (GPS) for Cancer Outcomes
Provides cancer prognosis based on serum biomarkers.
INSTRUCTIONS
Note: We recommend the Modified Glasgow Prognostic Score over this original version.
Result:
Please fill out required fields.
Dr. Donald McMillan
About the creator
Donald McMillan, MD, is a professor of surgical science at the University of Glasgow and an associate academic at the Institute of Cancer Sciences. His research focuses on systemic inflammatory response in weight loss and poor physical function, quality of life and survival of cancer patients.
To view Dr. Donald McMillan's publications, visit PubMed